Joseph DeRisi of the University of California at San Francisco proposes to engineer naturally occurring erythrotropic bacteria to target malaria infected red blood cells to serve as a potential prophylactic and treatment for malaria in humans.
Grant ID
OPP51756
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Initiatives
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False